Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Kiora Pharmaceuticals's total assets was $23.78M at Jun 30, 2026. For fiscal 2025 it was $24.25M, down 33.5% from the year before. Over ten years it grew 9.8% a year on average. The highest annual figure on record is $36.48M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.25M | -33.5% |
| FY2024 | Dec 31, 2024 | $36.48M | +166.1% |
| FY2023 | Dec 31, 2023 | $13.71M | -26.6% |
| FY2022 | Dec 31, 2022 | $18.68M | -7.2% |
| FY2021 | Dec 31, 2021 | $20.13M | +31.5% |
| FY2020 | Dec 31, 2020 | $15.30M | +51.3% |
| FY2019 | Dec 31, 2019 | $10.11M | -29.2% |
| FY2018 | Dec 31, 2018 | $14.28M | -0.2% |
| FY2017 | Dec 31, 2017 | $14.31M | +47.0% |
| FY2016 | Dec 31, 2016 | $9.73M | +2.3% |
| FY2015 | Dec 31, 2015 | $9.51M | +576.0% |
| FY2014 | Dec 31, 2014 | $1.41M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.78M | -25.6% |
| Q1 FY2026 | Mar 31, 2026 | $21.23M | -37.6% |
| Q4 FY2025 | Dec 31, 2025 | $24.25M | -33.5% |
| Q3 FY2025 | Sep 30, 2025 | $29.86M | -22.5% |
| Q2 FY2025 | Jun 30, 2025 | $31.95M | -21.7% |
| Q1 FY2025 | Mar 31, 2025 | $34.02M | -19.8% |
| Q4 FY2024 | Dec 31, 2024 | $36.48M | +166.1% |
| Q3 FY2024 | Sep 30, 2024 | $38.51M | +142.3% |
| Q2 FY2024 | Jun 30, 2024 | $40.81M | +105.3% |
| Q1 FY2024 | Mar 31, 2024 | $42.44M | +156.8% |
| Q4 FY2023 | Dec 31, 2023 | $13.71M | -26.6% |
| Q3 FY2023 | Sep 30, 2023 | $15.90M | -10.0% |
| Q2 FY2023 | Jun 30, 2023 | $19.88M | +28.6% |
| Q1 FY2023 | Mar 31, 2023 | $16.53M | -6.3% |
| Q4 FY2022 | Dec 31, 2022 | $18.68M | -7.2% |
| Q3 FY2022 | Sep 30, 2022 | $17.66M | -30.7% |
| Q2 FY2022 | Jun 30, 2022 | $15.46M | -14.6% |
| Q1 FY2022 | Mar 31, 2022 | $17.64M | -14.5% |
| Q4 FY2021 | Dec 31, 2021 | $20.13M | +31.5% |
| Q3 FY2021 | Sep 30, 2021 | $25.49M | +175.7% |
| Q2 FY2021 | Jun 30, 2021 | $18.10M | +65.0% |
| Q1 FY2021 | Mar 31, 2021 | $20.62M | +69.2% |
| Q4 FY2020 | Dec 31, 2020 | $15.30M | +51.3% |
| Q3 FY2020 | Sep 30, 2020 | $9.25M | +4.3% |
| Q2 FY2020 | Jun 30, 2020 | $10.97M | +0.7% |
| Q1 FY2020 | Mar 31, 2020 | $12.19M | -2.0% |
| Q4 FY2019 | Dec 31, 2019 | $10.11M | -29.2% |
| Q3 FY2019 | Sep 30, 2019 | $8.87M | -46.7% |
| Q2 FY2019 | Jun 30, 2019 | $10.90M | -42.8% |
| Q1 FY2019 | Mar 31, 2019 | $12.44M | +11.4% |
| Q4 FY2018 | Dec 31, 2018 | $14.28M | -0.2% |
| Q3 FY2018 | Sep 30, 2018 | $16.65M | +3.7% |
| Q2 FY2018 | Jun 30, 2018 | $19.06M | +4.1% |
| Q1 FY2018 | Mar 31, 2018 | $11.17M | -7.0% |
| Q4 FY2017 | Dec 31, 2017 | $14.31M | +47.0% |
| Q3 FY2017 | Sep 30, 2017 | $16.06M | +51.3% |
| Q2 FY2017 | Jun 30, 2017 | $18.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.73M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.62M | – |
See a number that looks wrong?